Company · CIK 0001401708 · SIC 2836 — Biological Products, (No Diagnostic Substances)
NanoString Technologies Inc · NSTG
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 1, 2016 AForm 4 → | Mar 3, 5:28 pm EST | R Bradley GrayPresident and CEO, Director | 2,232 | $9.52 | $21,249 | 96,706 | — | plan? |
| Jan 6, 2016 MForm 4 → | Jan 8, 3:10 pm EST | Wayne BurnsSVP, Operations & Admin | 57,206 | $2.05 | $117,485 | 61,178 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 1:47 pm EDT | Barney SaundersSVP, Sales & Marketing | 919 | $9.52 | $8,749 | 4,101 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 1:45 pm EDT | James A JohnsonChief Financial Officer | 761 | $9.52 | $7,245 | 3,709 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 1:43 pm EDT | R Bradley GrayPresident and CEO, Director | 1,173 | $9.52 | $11,167 | 94,474 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 1:39 pm EDT | David W. GhesquiereSVP, Corporate & Business Dev | 867 | $9.52 | $8,254 | 1,654 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 1:33 pm EDT | Wayne BurnsSVP, Operations & Admin | 945 | $9.52 | $8,996 | 3,972 | — | plan? |
| Sep 1, 2015 AForm 4 → | Sep 3, 1:31 pm EDT | Joseph M BeechemSVP, Research & Development | 924 | $9.52 | $8,796 | 4,351 | — | plan? |
| Aug 13, 2015 SForm 4 → | Aug 14, 7:51 pm EDT | Wayne BurnsSVP, Operations & Admin | 30,000 | $14.93 | $447,900 | 3,027 | −90.8% | plan? |
| Aug 10, 2015 SForm 4 → | Aug 11, 2:09 pm EDT | Barney SaundersSVP, Sales & Marketing | 27,242 | $15.08 | $410,888 | 3,182 | −89.5% | plan? |
| Aug 10, 2015 MForm 4 → | Aug 11, 2:09 pm EDT | Barney SaundersSVP, Sales & Marketing | 27,242 | $2.16 | $58,779 | 30,424 | — | plan? |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:43 pm EST | Barney SaundersSVP, Sales & Marketing | 827 | $9.52 | $7,873 | 3,182 | — | plan? |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:42 pm EST | James A JohnsonChief Financial Officer | 789 | $9.52 | $7,511 | 2,948 | — | plan? |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:41 pm EST | R Bradley GrayPresident and CEO, Director | 1,511 | $9.52 | $14,385 | 93,301 | — | plan? |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:40 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 787 | $9.52 | $7,492 | 787 | — | plan? |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:40 pm EST | Wayne BurnsSVP, Operations & Admin | 866 | $9.52 | $8,244 | 33,027 | — | plan? |
| Mar 2, 2015 AForm 4 → | Mar 4, 5:39 pm EST | Joseph M BeechemSVP, Research & Development | 880 | $9.52 | $8,378 | 3,427 | — | plan? |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 11, 2019 MForm 4 → | Mar 13, 4:13 pm EDT | Joseph M BeechemSVP, Research & Development | 18,431 | — | — | 30,196 | — | |
| Mar 11, 2019 MForm 4 → | Mar 13, 4:13 pm EDT | Mary Tedd AllenSVP, Operations | 15,882 | — | — | 25,098 | — | |
| Mar 11, 2019 MForm 4 → | Mar 13, 4:12 pm EDT | J. Chad BrownSVP, Sales & Marketing | 10,254 | — | — | 17,177 | — | |
| Mar 11, 2019 MForm 4 → | Mar 13, 4:11 pm EDT | R Bradley GrayPresident and CEO, Director | 54,313 | — | — | 88,628 | — | |
| Mar 11, 2019 MForm 4 → | Mar 13, 4:11 pm EDT | David W. GhesquiereSVP, Corporate & Business Dev | 18,039 | — | — | 29,412 | — | |
| Mar 7, 2019 MForm 4 → | Mar 11, 4:21 pm EDT | Joseph M BeechemSVP, Research & Development | 3,333 | — | — | 3,334 | — | |
| Mar 7, 2019 MForm 4 → | Mar 11, 4:20 pm EDT | Mary Tedd AllenSVP, Operations | 2,666 | — | — | 2,668 | — | |
| Mar 7, 2019 MForm 4 → | Mar 11, 4:19 pm EDT | David W. GhesquiereSVP, Corporate & Business Dev | 3,333 | — | — | 3,334 | — | |
| Mar 7, 2019 MForm 4 → | Mar 11, 4:18 pm EDT | R Bradley GrayPresident and CEO, Director | 10,000 | — | — | 10,000 | — | |
| Feb 4, 2019 MForm 4 → | Feb 6, 4:21 pm EST | Mary Tedd AllenSVP, Operations | 2,000 | — | — | 0 | — | |
| Feb 4, 2019 MForm 4 → | Feb 6, 4:19 pm EST | R Bradley GrayPresident and CEO, Director | 10,418 | — | — | 0 | — | |
| Feb 4, 2019 MForm 4 → | Feb 6, 4:14 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 4,168 | — | — | 0 | — | |
| Feb 4, 2019 MForm 4 → | Feb 6, 4:11 pm EST | Joseph M BeechemSVP, Research & Development | 4,168 | — | — | 0 | — | |
| Nov 12, 2018 MForm 4 → | Nov 14, 4:52 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 2,500 | — | — | 2,500 | — | |
| Oct 10, 2018 XForm 4 → | Oct 12, 4:05 pm EDT | Mary Tedd AllenSVP, Operations | 437 | — | — | 0 | — | |
| Oct 6, 2018 MForm 4 → | Oct 9, 5:57 pm EDT | Mary Tedd AllenSVP, Operations | 41,250 | $3.08 | $127,200 | 0 | — | |
| Sep 17, 2018 XForm 4 → | Sep 19, 4:46 pm EDT | Clarus Lifesciences II, L.P. +210% Owner | 162,408 | — | — | 0 | — | |
| Sep 17, 2018 XForm 4 → | Sep 19, 4:45 pm EDT | Nicholas GalakatosDirector, 10% Owner | 162,408 | — | — | 0 | — | |
| Mar 7, 2018 MForm 4 → | Mar 8, 4:42 pm EST | Joseph M BeechemSVP, Research & Development | 3,333 | — | — | 6,667 | — | |
| Mar 7, 2018 MForm 4 → | Mar 8, 4:42 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 3,333 | — | — | 6,667 | — | |
| Mar 7, 2018 MForm 4 → | Mar 8, 4:41 pm EST | R Bradley GrayPresident and CEO, Director | 10,000 | — | — | 20,000 | — | |
| Mar 7, 2018 MForm 4 → | Mar 8, 4:41 pm EST | Mary Tedd AllenSVP, Operations | 2,666 | — | — | 5,334 | — | |
| Mar 2, 2018 MForm 4 → | Mar 5, 6:37 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 5,000 | — | — | 0 | — | |
| Feb 6, 2018 AForm 4 → | Feb 8, 5:26 pm EST | J. Chad BrownSVP, Sales & Marketing | 40,765 | — | — | 30,765 | — | |
| Feb 5, 2018 AMForm 4 → | Feb 7, 6:16 pm EST | R Bradley GrayPresident and CEO, Director | 233,357 | — | — | 162,941 | — | |
| Feb 5, 2018 AMForm 4 → | Feb 7, 6:16 pm EST | Mary Tedd AllenSVP, Operations | 69,647 | — | — | 47,647 | — | |
| Feb 5, 2018 AMForm 4 → | Feb 7, 6:15 pm EST | Joseph M BeechemSVP, Research & Development | 79,460 | — | — | 55,294 | — | |
| Feb 5, 2018 AMForm 4 → | Feb 7, 6:14 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 78,284 | — | — | 54,118 | — | |
| Jan 16, 2018 AForm 4 → | Jan 18, 4:14 pm EST | K Thomas BaileyChief Financial Officer | 130,000 | — | — | 35,000 | — | |
| Jan 1, 2018 AForm 4 → | Jan 3, 6:20 pm EST | William YoungDirector | 10,168 | — | — | 10,168 | — | |
| Jan 1, 2018 AForm 4 → | Jan 3, 6:20 pm EST | Charles P Waite Jr.Director | 10,168 | — | — | 10,168 | — | |
| Jan 1, 2018 AForm 4 → | Jan 3, 6:20 pm EST | Gregory NordenDirector | 10,168 | — | — | 10,168 | — | |
| Jan 1, 2018 AForm 4 → | Jan 3, 6:19 pm EST | Robert HershbergDirector | 10,168 | — | — | 10,168 | — | |
| Jan 1, 2018 AForm 4 → | Jan 3, 6:19 pm EST | Elisha W FinneyDirector | 10,168 | — | — | 10,168 | — | |
| Jan 1, 2018 AForm 4 → | Jan 3, 6:19 pm EST | Kirk MalloyDirector | 10,168 | — | — | 10,168 | — | |
| Jan 1, 2018 AForm 4 → | Jan 3, 6:18 pm EST | Nicholas GalakatosDirector, 10% Owner | 10,168 | — | — | 10,168 | — | |
| Jan 1, 2018 AForm 4 → | Jan 3, 6:18 pm EST | Clarus Lifesciences II, L.P. +210% Owner | 10,168 | — | — | 10,168 | — | |
| Nov 13, 2017 AForm 4 → | Nov 15, 5:08 pm EST | J. Chad BrownSVP, Sales & Marketing | 17,200 | — | — | 17,200 | — | |
| Nov 13, 2017 MForm 4 → | Nov 15, 5:08 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 2,500 | — | — | 5,000 | — | |
| Aug 7, 2017 MForm 4 → | Aug 9, 5:54 pm EDT | R Bradley GrayPresident and CEO, Director | 41,926 | — | — | 0 | — | |
| Jul 5, 2017 AForm 4 → | Jul 6, 4:21 pm EDT | J. Chad BrownSVP, Sales & Marketing | 60,000 | — | — | 60,000 | — | |
| May 9, 2017 AForm 4 → | May 11, 1:09 pm EDT | Elisha W FinneyDirector | 17,353 | — | — | 17,353 | — | |
| Mar 2, 2017 MForm 4 → | Mar 3, 7:28 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 5,000 | — | — | 5,000 | — | |
| Feb 6, 2017 MForm 4 → | Feb 8, 5:59 pm EST | Barney SaundersSVP, Sales & Marketing | 3,333 | — | — | 6,667 | — | |
| Feb 6, 2017 AMForm 4 → | Feb 8, 5:58 pm EST | James A JohnsonChief Financial Officer | 33,333 | — | — | 20,000 | — | |
| Feb 6, 2017 AMForm 4 → | Feb 8, 5:56 pm EST | R Bradley GrayPresident and CEO, Director | 100,416 | — | — | 30,000 | — | |
| Feb 6, 2017 AMForm 4 → | Feb 8, 5:56 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 34,166 | — | — | 10,000 | — | |
| Feb 6, 2017 MForm 4 → | Feb 8, 5:54 pm EST | Wayne BurnsSVP, Operations & Admin | 14,407 | — | — | 0 | — | |
| Feb 6, 2017 AMForm 4 → | Feb 8, 5:52 pm EST | Joseph M BeechemSVP, Research & Development | 34,166 | — | — | 20,000 | — | |
| Jan 1, 2017 AForm 4 → | Jan 4, 8:42 pm EST | Clarus Lifesciences II, L.P. +210% Owner | 8,611 | — | — | 8,611 | — | |
| Jan 1, 2017 AForm 4 → | Jan 4, 6:13 pm EST | William YoungDirector | 8,611 | — | — | 8,611 | — | |
| Jan 1, 2017 AForm 4 → | Jan 4, 6:11 pm EST | Charles P Waite Jr.Director | 8,611 | — | — | 8,611 | — | |
| Jan 1, 2017 AForm 4 → | Jan 4, 6:09 pm EST | Gregory NordenDirector | 8,611 | — | — | 8,611 | — | |
| Jan 1, 2017 AForm 4 → | Jan 4, 6:07 pm EST | Kirk MalloyDirector | 8,611 | — | — | 8,611 | — | |
| Jan 1, 2017 AForm 4 → | Jan 4, 6:06 pm EST | Nicholas GalakatosDirector, 10% Owner | 8,611 | — | — | 8,611 | — | |
| Jan 1, 2017 AForm 4 → | Jan 4, 6:04 pm EST | Robert HershbergDirector | 8,611 | — | — | 8,611 | — | |
| Dec 23, 2016 MForm 4 → | Dec 27, 5:43 pm EST | R Bradley GrayPresident and CEO, Director | 8,000 | — | — | 127,588 | — | |
| Dec 5, 2016 MForm 4 → | Dec 7, 4:41 pm EST | Wayne BurnsSVP, Operations & Admin | 21,666 | — | — | 15,834 | — | |
| Nov 10, 2016 MForm 4 → | Nov 14, 8:49 pm EST | Barney SaundersSVP, Sales & Marketing | 7,882 | — | — | 625 | — | |
| Nov 10, 2016 MForm 4 → | Nov 14, 8:47 pm EST | James A JohnsonChief Financial Officer | 10,000 | — | — | 72,968 | — | |
| Nov 10, 2016 AForm 4 → | Nov 14, 8:45 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 22,500 | — | — | 15,000 | — | |
| Oct 26, 2016 XForm 4 → | Oct 28, 6:09 pm EDT | Charles P Waite Jr.Director | 103,404 | — | — | 0 | — | |
| Sep 12, 2016 AForm 4 → | Sep 13, 5:20 pm EDT | Kirk MalloyDirector | 15,935 | — | — | 15,935 | — | |
| Mar 2, 2016 MForm 4 → | Mar 3, 5:37 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 5,000 | — | — | 10,000 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 6:30 pm EST | Barney SaundersSVP, Sales & Marketing | 30,000 | — | — | 20,000 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 6:29 pm EST | James A JohnsonChief Financial Officer | 30,000 | — | — | 20,000 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 6:29 pm EST | R Bradley GrayPresident and CEO, Director | 93,750 | — | — | 62,500 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 6:26 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 37,500 | — | — | 25,000 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 6:25 pm EST | Joseph M BeechemSVP, Research & Development | 37,500 | — | — | 25,000 | — | |
| Feb 3, 2016 AForm 4 → | Feb 5, 6:24 pm EST | Wayne BurnsSVP, Operations & Admin | 30,000 | — | — | 20,000 | — | |
| Jan 6, 2016 MForm 4 → | Jan 8, 3:10 pm EST | Wayne BurnsSVP, Operations & Admin | 57,206 | — | — | 1,074 | — | |
| Jan 1, 2016 AForm 4 → | Jan 5, 5:04 pm EST | Clarus Lifesciences II, L.P. +210% Owner | 7,828 | — | — | 7,828 | — | |
| Jan 1, 2016 AForm 4 → | Jan 5, 4:43 pm EST | Gregory NordenDirector | 7,828 | — | — | 7,828 | — | |
| Jan 1, 2016 AForm 4 → | Jan 5, 4:41 pm EST | Charles P Waite Jr.Director | 7,828 | — | — | 7,828 | — | |
| Jan 1, 2016 AForm 4 → | Jan 5, 4:39 pm EST | Robert HershbergDirector | 7,828 | — | — | 7,828 | — | |
| Jan 1, 2016 AForm 4 → | Jan 5, 4:35 pm EST | William YoungDirector | 7,828 | — | — | 7,828 | — | |
| Jan 1, 2016 AForm 4 → | Jan 5, 4:33 pm EST | Nicholas GalakatosDirector, 10% Owner | 7,828 | — | — | 7,828 | — | |
| Aug 10, 2015 MForm 4 → | Aug 11, 2:09 pm EDT | Barney SaundersSVP, Sales & Marketing | 27,242 | — | — | 3,507 | — | |
| Mar 2, 2015 AForm 4 → | Mar 3, 6:12 pm EST | Robert HershbergDirector | 14,688 | — | — | 14,688 | — | |
| Feb 9, 2015 AForm 4 → | Feb 11, 5:29 pm EST | Barney SaundersSVP & GM, Life Sciences | 40,000 | — | — | 40,000 | — | |
| Feb 9, 2015 AForm 4 → | Feb 11, 5:29 pm EST | Wayne BurnsSVP, Operations & Admin | 40,000 | — | — | 40,000 | — | |
| Feb 9, 2015 AForm 4 → | Feb 11, 5:28 pm EST | Joseph M BeechemSVP, Research & Development | 45,000 | — | — | 45,000 | — | |
| Feb 9, 2015 AForm 4 → | Feb 11, 5:27 pm EST | R Bradley GrayPresident and CEO, Director | 100,000 | — | — | 100,000 | — | |
| Feb 9, 2015 AForm 4 → | Feb 11, 5:26 pm EST | James A JohnsonChief Financial Officer | 45,000 | — | — | 45,000 | — | |
| Feb 9, 2015 AForm 4 → | Feb 11, 5:25 pm EST | David W. GhesquiereSVP, Corporate & Business Dev | 60,000 | — | — | 45,000 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 7:57 pm EST | William YoungDirector | 7,307 | — | — | 7,307 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 7:57 pm EST | Charles P Waite Jr.Director | 7,307 | — | — | 7,307 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 7:56 pm EST | Gregory NordenDirector | 7,307 | — | — | 7,307 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 7:55 pm EST | Nicholas GalakatosDirector, 10% Owner | 7,307 | — | — | 7,307 | — | |
| Jan 1, 2015 AForm 4 → | Jan 5, 7:54 pm EST | Clarus Lifesciences II, L.P. +210% Owner | 7,307 | — | — | 7,307 | — |